Winston Tan, MD

Articles by Winston Tan, MD

Dr. Tan on Imaging Modalities in Prostate Cancer

ByWinston Tan, MD

August 15th 2019

Winston Tan, MD, hematologist/oncologist, Mayo Clinic, discusses imaging modalities in prostate cancer.

Dr. Tan Discusses the FDA Approval of Darolutamide in M0CRPC

ByWinston Tan, MD

July 31st 2019

Winston Tan, MD, hematologist/oncologist, Mayo Clinic, discusses the FDA approval of darolutamide (Nubeqa) in nonmetastatic castration-resistant prostate cancer (M0CRPC).

Latest Updated Articles

Dr. Tan Discusses the FDA Approval of Darolutamide in M0CRPC
Published: July 31st 2019 | Updated:
Dr. Tan on Imaging Modalities in Prostate Cancer
Published: August 15th 2019 | Updated:

Winston Tan, MD

Articles by Winston Tan, MD

Dr. Tan on Imaging Modalities in Prostate Cancer

Dr. Tan Discusses the FDA Approval of Darolutamide in M0CRPC

Latest Updated Articles

Trending on OncLive

FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma

Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer

PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer

Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma

Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies